Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study Evaluating the Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid Soft Tissue Endoprosthesis

NCT00333684 is registered in ClinicalTrials.gov with Canadian Immunodeficiency Research Collaborative as lead sponsor.

NCT NCT00333684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00333684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study Evaluating the Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid Soft Tissue Endoprosthesis
Lead sponsor
Canadian Immunodeficiency Research Collaborative
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2004
Completion date
May 31, 2010
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

facial lipoatrophy, human immunodeficiency virus